Patrick D. Kirwin is Director at ProMIS Neurosciences Inc. (PMN). They have made 5 open-market trades across 1 company since 2022, most recently 2026-04-22.
CIK 0001927062
5 open-market purchases totalling $100K since 2022, never a sale. Across 5 scored buys the stock is up 0.9% at ninety days, and 0.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PMN | 4,653 | $38K |
Shares reported on the most recent Form 4, priced at the 2026-04-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 60% | 60% |
| Avg Move | -0.4% | +2.9% | +0.9% |
| Alpha | +1.8% | +2.7% | +0.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PMN | BUY | 2026-04-22 | 2026-04-23 | $11.33 | $45K | -2.8% | -7.5% | +23.7% |
| PMN | BUY | 2024-08-14 | 2024-08-16 | $1.25 | $13K | -0.7% | +2.2% | -26.3% |
| PMN | BUY | 2022-12-13 | 2022-12-15 | $4.63 | $14K | +8.4% | +26.3% | +6.1% |
| PMN | BUY | 2022-12-09 | 2022-12-13 | $4.98 | $5K | -2.1% | +3.1% | -2.1% |
| PMN | BUY | 2022-08-17 | 2022-08-18 | $5.92 | $24K | -4.6% | -9.8% | +3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.